Globally, several key companies are actively working in the Age-related Macular Degeneration Therapeutics Market. The launch of the emerging therapies is expected to transform the treatment scenario in the coming years.
“Age-related Macular Degeneration Pipeline Insight, 2022” report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Age-related Macular Degeneration Market.
The Age-related Macular Degeneration Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.
Age-related Macular Degeneration Pipeline Analysis
The report provides insights into:
The report provides detailed insights about companies that are developing therapies for the treatment of Age-related Macular Degeneration with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for the Age-related Macular Degeneration Treatment.
Age-related Macular Degeneration key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Age-related Macular Degeneration Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Age-related Macular Degeneration market.
The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Request for Sample PDF Report – https://www.delveinsight.com/sample-request/age-related-macular-degeneration-amd-pipeline-insight
Age-related Macular Degeneration Therapeutics Landscape –
Age-related Macular Degeneration Mechanism of Action (MOA):
Placenta growth factor inhibitors
Vascular endothelial growth factor A inhibitors
Angiogenesis inhibitors
Colony stimulating factor receptor antagonists
Vascular endothelial growth factors inhibitors
Fibroblast growth factor inhibitors
Cell replacements
Age-related Macular Degeneration (AMD) Therapies covered in the report include:
GB-102
KSI 301
ADVM-022
OpRegen
ABP 938
RBM-007 Injectable Solution
And many more.
Some of the Key Companies in the Age-related Macular Degeneration (AMD) Market include:
Ribomic USA Inc.
Amgen
Lineage Cell Therapeutics, Inc.
Adverum Biotechnologies, Inc
Kodiak Sciences Inc.
Graybug Vision
And many others.
Get More Detailed Insights Into the Emerging Therapies & Key Companies: https://www.delveinsight.com/sample-request/age-related-macular-degeneration-amd-pipeline-insight
Table of Content (TOC)
1. Report Introduction
2. Executive Summary
3. Age-related Macular Degeneration Current Treatment Patterns
4. Age-related Macular Degeneration – DelveInsight’s Analytical Perspective
5. Therapeutic Assessment
6. Age-related Macular Degeneration Late Stage Products (Phase-III)
7. Age-related Macular Degeneration Mid-Stage Products (Phase-II)
8. Age-related Macular Degeneration Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Age-related Macular Degeneration Discontinued Products
13. Age-related Macular Degeneration Product Profiles
14. Key Companies in the Age-related Macular Degeneration Market
15. Key Products in the Age-related Macular Degeneration Therapeutics Segment
16. Dormant and Discontinued Products
17. Age-related Macular Degeneration Unmet Needs
18. Age-related Macular Degeneration Future Perspectives
19. Age-related Macular Degeneration Analyst Review
20. Appendix
21. Report Methodology
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report – https://www.delveinsight.com/sample-request/age-related-macular-degeneration-amd-pipeline-insight
About DelveInsightDelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
Structural Heart Devices Market“Structural Heart Devices Market” research report provides comprehensive insights into the historical and forecasted Structural Heart Devices market size, share, trends as well as the key companies and emerging products in the market.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Anuj RawatEmail: Send EmailPhone: 09650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/